<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1380242" created="09/11/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1380242</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="SRC-related_proto-oncogene" sem="DNA_family_or_group">SRC-related proto-oncogenes</term> and <term id="T2" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> in primary <term id="T3" lex="human_T_cell" sem="Cell_natural">human T cells</term>: modulation by <term id="T4" lex="cyclosporin_A" sem="Organic_compound_other">cyclosporin A</term> and <term id="T5" lex="FK506" sem="Organic_compound_other">FK506</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Regulation"/>
<theme idref="T1"/>
<cause idref="T4"/>
<clue>SRC-related proto-oncogenes and transcription factors <clueLoc>in primary human T cells</clueLoc>: <clueType>modulation</clueType> <linkCause>by</linkCause> cyclosporin A and FK506.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Regulation"/>
<theme idref="T1"/>
<cause idref="T5"/>
<clue>SRC-related proto-oncogenes and transcription factors <clueLoc>in primary human T cells</clueLoc>: <clueType>modulation</clueType> <linkCause>by</linkCause> cyclosporin A and FK506.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Regulation"/>
<theme idref="T2"/>
<cause idref="T4"/>
<clue>SRC-related proto-oncogenes and transcription factors <clueLoc>in primary human T cells</clueLoc>: <clueType>modulation</clueType> <linkCause>by</linkCause> cyclosporin A and FK506.</clue>
</event>
<event KT="Investigation" id="E4">
<type class="Regulation"/>
<theme idref="T2"/>
<cause idref="T5"/>
<clue>SRC-related proto-oncogenes and transcription factors <clueLoc>in primary human T cells</clueLoc>: <clueType>modulation</clueType> <linkCause>by</linkCause> cyclosporin A and FK506.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Activation of <term id="T6" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> induces transcription of <term id="A2" sem="DNA_domain_or_region"><term id="T7" lex="gene" sem="DNA_family_or_group">genes</term> encoding for <term id="T8" lex="lymphokine" sem="Protein_domain_or_region">lymphokines</term></term>.</sentence>
<event KT="Other" id="E5">
<type class="Physiological_process"/>
<theme idref="T6"/>
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> T lymphocytes induces transcription of genes encoding for lymphokines.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="E5"/>
<clue>Activation of T lymphocytes <clueType>induces</clueType> transcription of genes encoding for lymphokines.</clue>
</event>
<event KT="Other" id="E7">
<type class="Transcription"/>
<theme idref="A2"/>
<clue>Activation of T lymphocytes induces <clueType>transcription</clueType> <linkTheme>of</linkTheme> genes encoding for lymphokines.</clue>
<comment>TPS: A2</comment></event>
<sentence id="S3"><term id="T9" lex="Interleukin-2_(IL-2)_gene_expression" sem="Other"><term id="T10" lex="Interleukin-2_(IL-2)_gene" sem="DNA_domain_or_region"><term id="T11" lex="Interleukin-2" sem="Protein_molecule">Interleukin-2</term> (<term id="A3" sem="DNA_domain_or_region"><term id="T12" lex="IL-2" sem="Protein_molecule">IL-2</term>) gene</term></term> expression</term> is controlled transcriptionally by the cooperative activity of specific <term id="T13" lex="trans-activating_factor" sem="Protein_family_or_group">trans-activating factors</term> that bind to the <term id="T14" lex="IL-2_enhancer" sem="DNA_domain_or_region"><term id="T15" lex="IL-2" sem="Protein_molecule">IL-2</term> enhancer</term>.</sentence>
<event KT="Other" id="E8">
<type class="Transcription"/>
<theme idref="A3"/>
<clue>Interleukin-2 (IL-2) gene <clueType>expression</clueType> is controlled <clueType>transcriptionally</clueType> by the cooperative activity of specific trans-activating factors that bind to the IL-2 enhancer.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T13"/>
<clue>Interleukin-2 (IL-2) gene expression is <clueType>controlled</clueType> transcriptionally by the <clueType>cooperative</clueType> activity <linkCause>of</linkCause> specific trans-activating factors that bind to the IL-2 enhancer.</clue>
</event>
<event KT="Other" id="E10">
<type class="Binding"/>
<theme idref="T13"/>
<theme idref="T14"/>
<clue>Interleukin-2 (IL-2) gene expression is controlled transcriptionally by the cooperative activity of specific trans-activating factors that <clueType>bind</clueType> <linkTheme>to</linkTheme> the IL-2 enhancer.</clue>
</event>
<sentence id="S4"><term id="T16" lex="cyclosporin_A" sem="Organic_compound_other">Cyclosporin A</term> (<term id="T17" lex="CsA" sem="Organic_compound_other">CsA</term>) and <term id="T18" lex="FK506" sem="Organic_compound_other">FK506</term> inhibit the production of <term id="A4" sem="DNA_domain_or_region"><term id="T19" lex="IL-2" sem="Protein_molecule">IL-2</term></term> in <term id="T20" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> at the level of <term id="T21" lex="gene_transcription" sem="Other">gene transcription</term>.</sentence>
<event KT="Fact" id="E11">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T17"/>
<clue>Cyclosporin A (CsA) and FK506 <clueType>inhibit</clueType> the production of IL-2 in T lymphocytes at the level of gene transcription.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T18"/>
<clue>Cyclosporin A (CsA) and FK506 <clueType>inhibit</clueType> the production of IL-2 in T lymphocytes at the level of gene transcription.</clue>
</event>
<event KT="Other" id="E13">
<type class="Transcription"/>
<theme idref="A4"/>
<clue>Cyclosporin A (CsA) and FK506 inhibit the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-2 <clueLoc>in T lymphocytes</clueLoc> <clueType>at the level of gene transcription</clueType>.</clue>
</event>
<sentence id="S5">A member of the <term id="T22" lex="src_gene_family" sem="DNA_family_or_group">src gene family</term>, the <term id="T23" lex="lymphocyte-specific_protein_tyrosine_kinase" sem="Protein_molecule">lymphocyte-specific protein tyrosine kinase</term>, <term id="T24" lex="p56lck" sem="Protein_molecule">p56lck</term>, has been implicated in <term id="T25" lex="IL-2_production" sem="Other"><term id="T26" lex="IL-2" sem="Protein_molecule">IL-2</term> production</term>.</sentence>
<event CL="L2" KT="Analysis" id="E14">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="T24"/>
<clue>A member of the src gene family, the lymphocyte-specific protein tyrosine kinase, p56lck, has been <clueType><clueKT><clueCL>implicated</clueCL></clueKT></clueType> <linkTheme>in</linkTheme> IL-2 production.</clue>
</event>
<event KT="Other" id="E15">
<type class="Gene_expression"/>
<theme idref="T26"/>
<clue>A member of the src gene family, the lymphocyte-specific protein tyrosine kinase, p56lck, has been implicated in IL-2 <clueType>production</clueType>.</clue>
</event>
<sentence id="S6"><term id="T27" lex="CsA" sem="Organic_compound_other">CsA</term> was found not to inhibit <term id="T28" lex="lck_gene_expression" sem="Other"><term id="A5" sem="DNA_domain_or_region"><term id="T29" lex="lck" sem="Protein_molecule">lck</term> gene</term> expression</term>, nor the activity of the <term id="T30" lex="lck_gene_product" sem="Protein_molecule"><term id="T31" lex="lck_gene" sem="DNA_domain_or_region">lck gene</term> product</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E16">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T27"/>
<clue>CsA was <clueKT>found</clueKT> <cluePolarity>not</cluePolarity> to <clueType>inhibit</clueType> lck gene expression, nor the activity of the lck gene product.</clue>
</event>
<event id="E17">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>CsA was found not to inhibit lck gene <clueType>expression</clueType>, nor the activity of the lck gene product.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E18">
<type class="Negative_regulation"/>
<theme idref="T29"/>
<cause idref="T27"/>
<clue>CsA was <clueKT>found</clueKT> not to <clueType>inhibit</clueType> lck gene expression, <cluePolarity>nor</cluePolarity> the activity <linkTheme>of</linkTheme> the <corefTheme>lck gene product</corefTheme>.</clue>
</event>
<sentence id="S7">However, <term id="T32" lex="CsA" sem="Organic_compound_other">CsA</term> and <term id="T33" lex="FK506" sem="Organic_compound_other">FK506</term> inhibit the appearance of <term id="T34" lex="DNA_binding_activity" sem="Other"><term id="A6" sem="DNA_domain_or_region">DNA</term> binding activity</term> of <term id="A7" sem="Protein_molecule">factors</term> that bind to the <term id="T35" lex="NF-AT_site" sem="DNA_domain_or_region">NF-AT</term> and <term id="T36" lex="AP-1_site" sem="DNA_domain_or_region">AP-1 <term id="A1" sem="DNA_domain_or_region">sites</term></term> in the <term id="T37" lex="IL-2_enhancer" sem="DNA_domain_or_region"><term id="T38" lex="IL-2" sem="Protein_molecule">IL-2</term> enhancer</term>.</sentence>
<event id="E19">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T32"/>
<clue>However, CsA and FK506 <clueType>inhibit</clueType> the appearance of DNA binding activity of factors that bind to the NF-AT and AP-1 sites in the IL-2 enhancer.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T33"/>
<clue>However, CsA and FK506 <clueType>inhibit</clueType> the appearance of DNA binding activity of factors that bind to the NF-AT and AP-1 sites in the IL-2 enhancer.</clue>
</event>
<event KT="Other" id="E21">
<type class="Binding"/>
<theme idref="A6"/>
<theme idref="A7"/>
<clue>However, CsA and FK506 inhibit the appearance of DNA <clueType>binding</clueType> activity <linkTheme>of</linkTheme> factors that bind to the NF-AT and AP-1 sites in the IL-2 enhancer.</clue>
</event>
<event KT="Other" id="E22">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T35" idref1="A1"/>
<clue>However, CsA and FK506 inhibit the appearance of DNA binding activity of factors that <clueType>bind</clueType> <linkTheme>to</linkTheme> the NF-AT and AP-1 sites <clueLoc>in the IL-2 enhancer</clueLoc>.</clue>
</event>
<event KT="Other" id="E23">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T36"/>
<clue>However, CsA and FK506 inhibit the appearance of DNA binding activity of factors that <clueType>bind</clueType> <linkTheme>to</linkTheme> the NF-AT and AP-1 sites <clueLoc>in the IL-2 enhancer</clueLoc>.</clue>
</event>
<sentence id="S8">Since the induction of <term id="T39" lex="NF-AT" sem="Protein_family_or_group">NF-AT</term> and <term id="T40" lex="AP-1" sem="Protein_molecule">AP-1</term> is induced by the same <term id="A8" sem="Other">stimuli</term> that stimulate <term id="T41" lex="IL-2_production" sem="Other"><term id="T42" lex="IL-2" sem="Protein_molecule">IL-2</term> production</term>, these results indicate that the <term id="T43" lex="immunosuppressant_action" sem="Other">immunosuppressant action</term> of <term id="T44" lex="CsA" sem="Organic_compound_other">CsA</term> and <term id="T45" lex="FK506" sem="Organic_compound_other">FK506</term> is exerted at the level of these <term id="T46" lex="trans-activating_factor" sem="Protein_family_or_group">trans-activating factors</term>.</sentence>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="T39"/>
<clue>Since the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 production, these results indicate that the immunosuppressant action of CsA and FK506 is exerted at the level of these trans-activating factors.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="T40"/>
<clue>Since the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 production, these results indicate that the immunosuppressant action of CsA and FK506 is exerted at the level of these trans-activating factors.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="A8"/>
<clue>Since the induction of NF-AT and AP-1 is <clueType>induced</clueType> <linkCause>by</linkCause> the same stimuli that stimulate IL-2 production, these results indicate that the immunosuppressant action of CsA and FK506 is exerted at the level of these trans-activating factors.</clue>
</event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="A8"/>
<clue>Since the induction of NF-AT and AP-1 is <clueType>induced</clueType> <linkCause>by</linkCause> the same stimuli that stimulate IL-2 production, these results indicate that the immunosuppressant action of CsA and FK506 is exerted at the level of these trans-activating factors.</clue>
</event>
<event KT="Other" id="E28">
<type/>
<theme idref="E29"/>
<cause idref="A8"/>
<clue>Since the induction of NF-AT and AP-1 is induced by the same stimuli that <clueType>stimulate</clueType> IL-2 production, these results indicate that the immunosuppressant action of CsA and FK506 is exerted at the level of these trans-activating factors.</clue>
</event>
<event KT="Other" id="E29">
<type class="Gene_expression"/>
<theme idref="T42"/>
<clue>Since the induction of NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 <clueType>production</clueType>, these results indicate that the immunosuppressant action of CsA and FK506 is exerted at the level of these trans-activating factors.</clue>
</event>
<event CL="L2" KT="Analysis" id="E30">
<type class="Negative_regulation"/>
<theme idref="T39"/>
<cause idref="T44"/>
<clue>Since the induction of NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 production, these results <clueKT><clueCL>indicate</clueCL></clueKT> that the <clueType>immunosuppressant action</clueType> <linkCause>of</linkCause> CsA and FK506 is <clueType>exerted</clueType> <linkTheme>at the level of</linkTheme> <corefTheme>these trans-activating factors</corefTheme>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E34">
<type class="Negative_regulation"/>
<theme idref="T39"/>
<cause idref="T45"/>
<clue>Since the induction of NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 production, these results <clueKT><clueCL>indicate</clueCL></clueKT> that the <clueType>immunosuppressant action</clueType> <linkCause>of</linkCause> CsA and FK506 is <clueType>exerted</clueType> <linkTheme>at the level of</linkTheme> <corefTheme>these trans-activating factors</corefTheme>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E31">
<type class="Negative_regulation"/>
<theme idref="T40"/>
<cause idref="T44"/>
<clue>Since the induction of NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 production, these results <clueKT><clueCL>indicate</clueCL></clueKT> that the <clueType>immunosuppressant action</clueType> <linkCause>of</linkCause> CsA and FK506 is <clueType>exerted</clueType> <linkTheme>at the level of</linkTheme> <corefTheme>these trans-activating factors</corefTheme>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E35">
<type class="Negative_regulation"/>
<theme idref="T40"/>
<cause idref="T45"/>
<clue>Since the induction of NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 production, these results <clueKT><clueCL>indicate</clueCL></clueKT> that the <clueType>immunosuppressant action</clueType> <linkCause>of</linkCause> CsA and FK506 is <clueType>exerted</clueType> <linkTheme>at the level of</linkTheme> <corefTheme>these trans-activating factors</corefTheme>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E32">
<type class="Regulation"/>
<theme idref="T46"/>
<cause idref="T44"/>
<clue>Since the induction of NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 production, these results <clueKT><clueCL>indicate</clueCL></clueKT> that the immunosuppressant action of CsA and FK506 is <clueType>exerted</clueType> <linkTheme>at the level of</linkTheme> these trans-activating factors.</clue>
</event>
<event CL="L2" KT="Analysis" id="E33">
<type class="Regulation"/>
<theme idref="T46"/>
<cause idref="T45"/>
<clue>Since the induction of NF-AT and AP-1 is induced by the same stimuli that stimulate IL-2 production, these results <clueKT><clueCL>indicate</clueCL></clueKT> that the immunosuppressant action of CsA and FK506 is <clueType>exerted</clueType> <linkTheme>at the level of</linkTheme> these trans-activating factors.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
